Bayer, EDB to fund S$30m regional disease research
Effort will deepen cancer research and expand into heart and eye diseases
Singapore
PHARMACEUTICAL giant Bayer HealthCare and the Singapore Economic Development Board (EDB) will jointly foster translational and clinical research for diseases prevalent in Asia over the next five years, they announced at a launch ceremony on Wednesday.
EDB will facilitate collaborations between Bayer HealthCare and its partner institutes - including SingHealth Duke-NUS Academic Medical Centre and National University Health System (NUHS) - to increase existing research efforts in cancer treatment, and expand into the research of heart and eye diseases.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
UK exits recession with fastest growth in nearly three years
Europe’s rush for rate cuts shifts global market power away from US
China’s push for greener aluminium hit by erratic rains, power cuts
Saudi crown prince to visit Japan
JPMorgan says India index inclusion on track, clients ready
Japan’s consumer spending extends declines as outlook weakens